Internal Medicine, Hematology & Oncology · Houston, TX
NPI
1548292980
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1631 North Loop W, Suite # 100
Houston, TX, 77008
Phone (713) 862-5695
Groups this clinician bills Medicare through
Medicare paid, 2024
$395K
13,098 services
Medicare patients, 2024
200
Average age 74
Drug cost, 2024
$3.2M
1,603 prescriptions
Company payments, 2025
$804
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahab A Khan was code 99213 (office e&m - established), 468 times for 128 patients. In total Shahab A Khan billed 13,098 services in 47 codes, and Medicare paid $395K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 468 | 128 | $60.76 | $28K |
| 36415 Venipuncture Blood Collection | Office | 450 | 130 | $8.65 | $3,893 |
| 85025 Blood Count | Office | 419 | 126 | $7.61 | $3,189 |
| 99232 Hospital E&M - Subsequent | Facility | 316 | 69 | $56.97 | $18K |
| 99223 Hospital E&M - Initial | Facility | 81 | 78 | $123.84 | $10K |
| 99214 Office E&M - Established | Office | 28 | 23 | $90.28 | $2,528 |
| 99204 Office E&M - New | Office | 19 | 19 | $116.98 | $2,223 |
By year: 2022 $478K for 18,045 services; 2023 $146K for 10,431 services; 2024 $395K for 13,098 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 450 | 130 | $8.65 | $3,893 |
| 85025 Blood Count | 419 | 126 | $7.61 | $3,189 |
Medicare prescription drug claims, 2024
In 2024, the drug Shahab A Khan prescribed most often to Medicare patients was Eliquis (Apixaban), with 238 prescriptions and refills. In total Shahab A Khan wrote 1,603 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 238 | 283 | 56 | $163K |
| Tamoxifen Citrate Generic | 77 | 163 | 17 | $1,603 |
| Warfarin Sodium Generic | 73 | 111 | Under 11 | $354 |
| Mvasi Bevacizumab-Awwb | 69 | 69 | Under 11 | $295K |
| Ondansetron Hcl Generic | 64 | 64 | 21 | $411 |
| Leucovorin Calcium Generic | 60 | 60 | Under 11 | $5,982 |
| Xarelto Rivaroxaban | 55 | 91 | 16 | $51K |
| Dexamethasone Generic | 52 | 52 | Under 11 | $671 |
| Anastrozole Generic | 52 | 102 | 15 | $352 |
| Oxaliplatin Generic | 51 | 51 | Under 11 | $5,532 |
| Hydroxyurea Generic | 48 | 93 | Under 11 | $732 |
| Xgeva Denosumab | 40 | 40 | Under 11 | $129K |
| Abiraterone Acetate Generic | 40 | 40 | Under 11 | $76K |
| Prednisone Generic | 38 | 40 | 13 | $98.9 |
| Irinotecan Hcl Generic | 27 | 27 | Under 11 | $2,261 |
Brand drugs: 652 claims; generic drugs: 951 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahab A Khan $804 ($804 in general payments such as food, travel and fees) from 18 companies. The largest payer was Eisai Inc. with $105.
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. 4523.T | 4 | $105 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $82.41 |
| Merck Sharp & Dohme LLC MRK | 3 | $78.9 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $78.39 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $67.14 |
| Incyte Corporation INCY | 3 | $62.7 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $40.92 |
| Genzyme Corporation SNY | 1 | $36.74 |
| Deciphera Pharmaceuticals Inc. | 1 | $34.53 |
| Kite Pharma, Inc. GILD | 1 | $33.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.